Answers are grounded in this paper and cite their sources.
Abdominal aortic aneurysm (AAA) lacks effective pharmacological therapies to prevent disease progression. Although gut microbial dysbiosis has been associated with AAA, existing studies have focused predominantly on gut-derived metabolites, and whether viable tissue-associated bacteria are present within the aneurysmal aortic wall and directly contribute to local vascular inflammation remains unclear. We therefore investigated the presence of tissue-associated bacteria in AAA and examined whether Prevotella copri contributes to AAA progression and the underlying mechanisms. Human AAA tissues and normal abdominal aortic tissues from liver transplantation donors were analyzed using 16 S rRNA gene sequencing, bacterial culture, transmission electron microscopy, and histological approaches. Angiotensin II (Ang II)- and elastase-induced mouse models, antibiotic cocktail treatment, and a tissue-clearing and D-amino-acid-labeling strategy (TiDaL) combining in vivo bacterial labeling, CUBIC-based tissue clearing, and whole-mount imaging were used to investigate the localization and effects of P. copri . Bacterial–macrophage co-culture, lactylation proteomics, immunoprecipitation, TPX2 K719R mutation, and TPX2 loss-of-function experiments were performed to investigate the underlying mechanism. In an exploratory human cohort ( n = 5 per group), AAA tissues showed altered microbial composition and a higher abundance of P. copri than normal abdominal aortic tissues ( P = 0.0363); P. copri was also detected by bacterial culture in human AAA tissues. In mice, aortic P. copri abundance was positively correlated with aortic diameter (R² = 0.9328), and labeled orally administered P. copri was detected within abdominal aortic tissues. P. copri exposure increased AAA incidence ( P < 0.0001), reduced survival ( P = 0.0498), and promoted macrophage M1 polarization and pro-inflammatory cytokine expression. Mechanistically, P. copri increased macrophage lactate and protein lactylation and induced TPX2 lactylation at lysine 719 (K719), thereby enhancing the interaction between TPX2 and NLRP3. The K719R mutation markedly weakened this interaction, whereas TPX2 silencing reduced NLRP3 expression and attenuated P. copri -associated AAA severity in vivo, including reductions in AAA incidence and aneurysmal dilation. Exploratory human data demonstrate an association between increased P. copri abundance and AAA tissue, while experimental findings support a contributory role of P. copri in AAA progression through TPX2 K719 lactylation and enhanced TPX2–NLRP3 signaling. The P. copri –TPX2 lactylation axis represents a candidate mechanism and potential therapeutic target that requires validation in larger human cohorts with appropriate disease controls. Hypothetical schematic of Prevotella copri-Driven Abdominal Aortic Aneurysm Progression via Promoting TPX2-K719 Lactylation and Regulating the NLRP3 Inflammasome. In disease states, the abundance of Prevotella copri is significantly increased in the diseased vascular tissues of abdominal aortic aneurysm. P. copri promotes enhanced glycolytic metabolism in macrophages, thereby increasing intracellular lactate levels and inducing lactylation modification at the lysine 719 (K719) site of the TPX2 protein. This modification significantly enhances the interaction between TPX2 and NLRP3, upregulates NLRP3 expression, and ultimately exacerbates local inflammatory responses in the lesion, driving the development and progression of AAA
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: